In evidence generated from a ten-year study on Traumatic Brain Injury, or TBI, a team led by researchers from Rutgers University have found two molecules that could be the key to the development of new drugs used to treat traumatic brain injuries.
According to Mayo Clinic a TBI is described as the following;
Traumatic brain injury usually results from a violent blow or jolt to the head or body. An object that penetrates brain tissue, such as a bullet or shattered piece of skull, also can cause traumatic brain injury.
Mild traumatic brain injury may affect your brain cells temporarily. More-serious traumatic brain injury can result in bruising, torn tissues, bleeding and other physical damage to the brain. These injuries can result in long-term complications or death.”